Gastric mucosa-associated lymphoid tissue lymphoma

American Journal of Gastroenterology

Volumn 98, Issue 5, 2003, Pages 975-986

  Ahmad, Asyia ^a   Govil, Yogesh ^a   Frank, Barbara B ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADVANCED CANCER; B LYMPHOCYTE; CANCER INFILTRATION; CANCER STAGING; CHRONIC GASTRITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENDOSCOPY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; LYMPH FOLLICLE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; REVIEW; STOMACH BIOPSY; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 0038071468     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07424.x     Document Type: Review

References (99)

1. Hermann R, Panahon AM, Barcos MP, et al. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980;46:215-22.
2. Lewin KJ, Ranchod M, Dorfman RF, et al. Lymphomas of the gastrointestinal tract: A study of 117 cases presenting with gastrointestinal disease. Cancer 1978;42:693-707.
3. Isaacson PG. Gastric lymphoma and Helicobacter pylori. N Engl J Med 1994;330:1310-11.
4. Isaacson PG, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:141-6.
5. Taal BG, Boot H, van Heerde P, et al. Primary non-Hodgkin's lymphoma of the stomach: Endoscopic pattern and prognosis in low- versus high-grade malignancy in relation to the MALT concept. Gut 1996;39:556-61.
6. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 1987;11:445-62.
7. Chan JKC, Ng CS, Isaacson PG. Relationship between highgrade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma). Am J Pathol 1990;136:1153-64.
8. Wotherspoon AC, Finn T, Isaacson PG, et al. Numerical abnormalities of chromosome 3 and 7 in lymphomas associated lymphoid tissue and the splenic marginal zone. Lab Invest 1994;70:1247.
9. Weingrad DN, Decosse JJ, Sherlock P, et al. Primary gastrointestinal lymphoma: A 30-year review. Cancer 1982;49:1258-65.
10. Joensuu H, Soderostrom KO, Kiemi PJ, et al. Nuclear DNA content and its prognostic value in lymphoma of the stomach. Cancer 1987;60:3042-8.
11. Genta RM, Hammer RW, Graham DY, et al. Gastric lymphoid follicles in Helicobacter pylori infection: Frequency, distribution and response to therapy. Hum Pathol 1993;24:577-83.
12. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
13. Talanonti MS, Dawes LG, Joehl RJ, et al. Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg 1990;125:972-7.
14. Doglioni C, Wotherspoon AC, Moschini A, et al. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992;339:834-5.
15. Parsonnet J, Hansen S, Rodriquez L, et al. Helicobacterpylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
16. Hussel T, Isaacson PG, Crabtree JE, et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
17. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Lancet 1993;342:575-7.
18. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helico-bacterpylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-9.
19. Ryuichi N, Takeda H. Regression of duodenal mucosa-associated lymphoid tissue after eradication of Helicobacter pylori. Gastroenterology 1996;111:1674-8.
20. Wotherspoon AC, Diss TC, Pan LX, et al. Synchronous gastric and intestinal lymphomas of MALT-type. J Pathol 1993;170(suppl):A67 (abstract).
21. Du MQ, Xu CF, Diss TC, et al. Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. Blood 1996;12:4445-51.
22. Isaacson PG. Lymphomas of mucosa-associated lymphoid tissue (MALT-type lymphomas). Forum 1993;3:234.
23. Wotherspoon AC, Doglioni C, Isaacson PG, et al. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): A multifocal disease. Histopathology 1992;20:29-34.
24. Xiang Z, Censini S, Bayelli PF, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helico-bacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
25. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991;338:332-5.
26. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993;90:5791-5.
27. Xiang Z, Bugnoli M, et al. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kDa protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1993;12:739-45.
28. Xiang Z, Bugnoli M, Rappuoli R, et al. Helicobacter pylori: Host responses in peptic ulceration. Lancet 1993;341:900-1.
29. Cover TL, Glupezynski Y, Lage AP, et al. Serological detection of infection with CagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33:1496-500.
30. Peek RM, Miller GG, Tham KT, et al. Heightened inflammatory response and cytokine expression in vivo to CagA+ Helicobacter pylori strains. Lab Invest 1995;71:760-70.
31. Crabtree JE, Wyatt JI, Sobola GM, et al. Systemic and mucosal humoral immune response to Helicobacter pylori in gastric cancer. Gut 1993;34:1339-43.
32. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacterpylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
33. Eck M, Schmauber B, Haas R, et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997;112:1482-6.
34. Crabtree JE, Spencer J. Immunologic aspects of Helicobacter pylori infection and malignant transformation of B cells. Semin Gastrointest Dis 1996;7:30-40.
35. Forester EC, Koch P, Koch O, et al. Serum response to Helicobacter pylori in primary B-cell gastric lymphoma. Gut 1995;37(suppl):A24 (abstract).
36. Witherell HL, Parsonnet J. Risk for gastric lymphoma in persons with Cag-A positive and Cag-A negative Helicobacter pylori infection. Gastroenterology 1997;112:A681 (abstract).
37. Chang C-S, Chen L-T, Yang J-C, et al. Isolation of a Helicobacterpylori protein, FldA associated with mucosa-associated lymphoid tissue lymphoma of the stomach. Gastroenterology 1999;117:82-8.
38. Kawahara Y, Yokota K, Mizuno M, et al. Antibodies to human gastric epithelial cells and heat shock protein 60 in Helicobacter pylori-positive mucosa-associated lymphoma tissue lymphoma. Gut 1999;45:20-3.
39. Neumeister P, Hoefler G, Deham-Schmid C, et al. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology 1997;112:1871-5.
40. Horsman D, Gascoyne R, Klasa R, et al. t(11;18)(q21;q21.1): A recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)? Genes Chromosomes Cancer 1992;4:183-7.
41. Amer MH, El-akkad S. Gastrointestinal lymphomas in adults. Clinical features and management of 300 cases. Gastroenterology 1994;106:846-58.
42. Ruskone-Fourmestraux A, Aegerter P, Delmer A, et al. Primary digestive tract lymphoma: A prospective multicenter study of 91 patients. Gastroenterology 1993;105:1662-71.
43. Taal BG, den Hartog Jager FCA, Burgers JMV, et al. Primary non-Hodgkin's lymphoma of the stomach: Changing aspects and therapeutic choices. Eur J Cancer Clin Oncol 1989;25:439-50.
44. Seifert E, Schulte F, Weismuller J, et al. Endoscopic and bioptic diagnosis of malignant non-Hodgkin's lymphoma of the stomach. Endoscopy 1993;25:497-501.
45. Kolve M, Fischbach W, Greiner A, et al. Differences in endoscopic and clinicopathological features of primary and secondary gastric non-Hodgkin's lymphoma. German Gastrointestinal Lymphoma Study Group. Gastrointest Endosc 1999;49:307-15.
46. Suekane H, Iida M, Kuwano Y, et al. Diagnosis of early gastric lymphoma: Usefulness of endoscopic mucosal resection for histologic evaluation. Cancer 1993;71:1207-13.
47. Nelson RS, Lanza FL. The endoscopic diagnosis of gastric lymphoma: Gross characteristics and histology. Gastrointest Endosc 1974;21:66-8.
48. Arista-Nasr J, Jiminez A, Keirns C, et al. The role of the endoscopic biopsy in the diagnosis of gastric lymphoma: A morphologic and immunohistochemical reappraisal. Hum Pathol 1993;22:239-48.
49. Alaglara P, Martinez P, Sanhez L, et al. The detection of B-cell monoclonal populations by polymerase chain reaction: Accuracy of approach and application in gastric endoscopic biopsy specimens. Hum Pathol 1993;24:1184-8.
50. Tio TL, den Hartog Jager FCA, Tytgat GNJ. Endoscopic ultrasonography of non-Hodgkin's lymphoma of the stomach. Gastroenterology 1986;91:401-8.
51. Bolondi L, Casanova P, Caletti GC, et al. Primary gastric lymphoma versus gastric carcinoma: Endoscopic US evaluation. Radiology 1987;165:821-6.
52. Calleti GC, Ferriari A, Brocchi E, et al. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993;113:14-27.
53. Suekane H, lida M, Yao T, et al. Endoscopic ultrasonography in primary gastric lymphoma: Correlation with endoscopic and histologic findings. Gastrointest Endosc 1993;39:139-45.
54. Levy M, Hammel P, Dominique L, et al. Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc 1997;46:328-33.
55. Palazzo L, Roseau G, Ruskone-Fourmestraux T, et al. Endoscopic ultrasonography in the local staging of primary gastric lymphoma. Endoscopy 1993;25:502-58.
56. Sackmann M, Morgner A, Rudolph B, et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. Gastroenterology 1997;113:1087-90.
57. Zuckerberg LR, Ferry JA, Southern JF, et al. Lymphoid infiltrates of the stomach. Evaluation of histologic criteria for the diagnosis of low-grade gastric lymphoma on endoscopic specimens. Am J Surg Pathol 1990;14:1087-99.
58. Jacobs DS. Primary gastric malignant lymphoma and pseudolymphoma. Am J Clin Pathol 1963;40:379-94.
59. Tokunaga O, Watanabet T, Morimatsu M. Pseudolymphoma of the stomach: A clinicopathologic study of 15 cases. Cancer 1987;59:1320-7.
60. Abbondanzo SL, Sobin LH. Gastric "pseudolymphoma": A retrospective morphologic and immunophenotypic study of 97 cases. Cancer 1997;79:1656-63.
61. Genta RM, Graham DY. Primary gastric MALT lymphoma: Trivial condition or serious disease? Helicobacter 1997;(suppl 1):S56-60.
62. Arista-Masr J, Herrera-Goepfert R, Lalzos-Ochoa M, et al. Histologic changes of the gastric mucosa associated with primary gastric lymphoma in endoscopic biopsy specimens. Arch Path Lab Med 2000;124:1628-31.
63. Villuendas R, Piris MA, Orradre JL, et al. Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue. Am J Pathol 1991;139:989-93.
64. Du M, Peng H, Sing N, et al. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995;86:4587-93.
65. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in lowgrade lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-4.
66. Peng H, Cheng G, Du M, et al. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 1996;148:643-8.
67. Kim YH, Lim HK, Han JK, et al. Low-grade gastric mucosa-associated lymphoid tissue lymphoma: Correlation of radiographic and pathologic findings. Radiology 1999;212:241-8.
68. Grau E, Gomez A, Cunat A, et al. Computed tomography in staging of primary gastric lymphoma. Lancet 1996;347:1261 (letter).
69. Stolte M, Bayerdorffer E, Morgner A, et al. Helicobacter and gastric MALT lymphoma. Gut 2002;50:19-24.
70. Levy M, Copie-Bergman C, Traulle C, et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: Predictive factors. Am J Gastroenterol 2002;97:292-7.
71. Nakamura S, Matsumoto T, Suekane H, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gastrointest Endoscop 2002;55:449-51.
72. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001;48:297-303.
73. Savio A, Zamboni G, Capelli P, et al. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: True relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the northeast of Italy and evaluation of diagnostic protocol's adequacy. Recent Results Cancer Res 2000;156:116-24.
74. Cavalli F, Isaacson P, Gascoyne R, et al. MALT lymphomas. Hematology 2001;241-58.
75. Levy M, Copie-Bergman C, Traulle C, et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: Predictive factors. Am J Gastroenterol 2002;97:292-7.
76. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999;131:88-95.
77. Pinotti G, Zucca E, Roggero E, et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997;26:527-37.
78. Ng W, Lam C, Chau W. Regression of high-grade mucosaassociate lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy. Gastrointest Endosc 2000;51:1-5.
79. Morgner A, Bayerdorffer E, Neubauer A, Stolte M. Helicobacter pylori associated gastric B cell MALT lymphoma: Predictive factors for regression. Gut 2001;48:290-2.
80. Matsushima Y, Kinoshita Y, Fukui H, et al. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication? J Gastroenterol 2002;37:428-33.
81. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 1992;102:1628-38.
82. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998;16:1916-21.
83. Iocher M, Muller R, Ross D, et al. Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma. Radiother Oncol 1997;42:37-41.
84. Hammel P, Haioun C, Chaumette M, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995;13:2524-9.
85. Conconi A, Thieblemont C, Martinelli G, et al. An International Extranodal Lymphoma Study Group Phase II study of Rituximab in extranodal marginal zone B-cell lymphomas. ASCO 2001;20:296a (abstract).
86. Urakami Y, Sano T, Begum S, et al. Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue. J Gastroenterol Hepatol 2000;15:1113-9.
87. Ishihara R, Tatsuta M, Iishi H, et al. Usefulness of endoscopic appearance for choosing a biopsy target site and determining a complete remission of primary gastric lymphoma of gastric mucosa-associated lymphoid tissue after eradication of Helicobacter pylori infection. Am J Gastroenterol 2002;97:772-4.
88. Montalban C, Santon A, Boixeda D, et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 2001;86:609-17.
89. Holland J, Trenker DA, Wasserman TH, et al. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992;69:1513-7.
90. Remigio PA, Klaum A. Extramedullary plasmacytoma of stomach. Cancer 1971;27:562-8.
91. Ooi A, Nakanishi I, Hashiba A. Gastric plasmacytoma: An early lesion diagnosed with the aid of immunoperoxidase and immunogold techniques. Am J Gastroenterol 1987;82:572-8.
92. Vasilu T, Popa R. The class of gastrointestinal tumors known as plasmacytoma. CR Soc Biol 1928;98:738-40.
93. Goyal A, Langer J, Zutter M, et al. Primary gastric plasmacytoma: A rare cause of hypertrophic gastritis in an adolescent. J Pediatr Gastroenterol Nutr 1999;29:424-30.
94. Matsumoto Y, Matsumoto T, Nakamura S, et al. Primary ileal plasmacytoma arising in mixed low- and high-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Abdom Imaging 2000;25:139-41.
95. Nakanashi I, Kajikawa K, Migita S, et al. Gastric plasmacytoma. An immunologic and immunobiochemical study. Cancer 1982;49:2025-8.
96. Woodruff R, Whittle J, Malpas J. Solitary plasmacytoma I: Extramedullary soft tissue plasmacytoma. Cancer 1979;43:2340-3.
97. Greenberg P, Parker R, Fu Y, et al. The treatment of solitary plasmacytoma of bone and extramedullary plasmacytoma. Am J Clin Oncol 1987;10:199-204.
98. Lin OS, Gray GM. Immunoproliferative small intestinal disease: Prolonged 30-year course without development of lymphoma. Am J Gastroenterol 2001;96:2769-74.
99. Kodama Y, Notohara K, Fujimori T, et al. MALT lymphoma. Simulating an extrmedullary plasmacytoma of the stomach. Am J Med 1999;107:530-2.